Background {#Sec1}
==========

Replication of the genome is an essential step in cell cycle progression and proliferation. Failure in this process will lead to abnormal cell proliferation, cell cycle arrest, and genomic instability \[[@CR1]--[@CR3]\]. At the heart of DNA replication, proliferating cell nuclear antigen (PCNA) has an essential role in orchestrating normal DNA synthesis by providing a platform to which DNA polymerases and other factors bind via the PIP box \[[@CR4]\]. PCNA, a ring-shaped sliding clamp, encircles DNA by the dimerization (prokaryotes) or trimerization (eukaryotes) of monomers \[[@CR5]--[@CR7]\]. Post-translational modifications (PTMs) of PCNA facilitate these protein interactions and are essential for the high processivity and accuracy of DNA synthesis. Modifications on PCNA, carried by "writers," profoundly regulate the interaction between PCNA and its partners. Phosphorylation, acetylation, ubiquitination, and sumoylation on PCNA have been strongly suggested to regulate DNA replication by affecting the binding affinity of PCNA partners or the stability of PCNA \[[@CR8]--[@CR11]\]. Additionally, SETD8, a methyltransferase, has been reported to interact with, and methylate PCNA \[[@CR12], [@CR13]\].

Protein lysine methylation has been widely elucidated in histone modification \[[@CR14], [@CR15]\]. However, accumulating non-histone proteins have been reported to be methylated by histone methyltransferases \[[@CR16], [@CR17]\]. Enhancer of zeste homologue 2 (EZH2), a methyltransferase, is primarily responsible for the trimethylation of histone H3 lysine 27 (H3K27me3) \[[@CR18]--[@CR21]\]. In addition, EZH2 has been reported to methylate non-histone proteins, such as cardiac transcription factor 4 (GATA4), retinoic acid-related orphan nuclear receptor α (RORα), and signal transducer and activator of transcription 3 (STAT3) \[[@CR22]--[@CR24]\]. EZH2 is positively related to proliferation, and its role as a transcriptional silencer via repression of INK4A/ARF is well established \[[@CR25]--[@CR27]\]. Beyond its role as the transcriptional repressor, EZH2 was also reported to localize at the replication fork by interacting with histone in response to DNA damage \[[@CR28], [@CR29]\]. Moreover, a recent study suggests that Polycomb (PcG) repressive complexes (PRCs) control proliferation independent of transcriptional repression of cell cycle-regulating genes \[[@CR30]\]. However, there is still a lack of evidence indicating whether EZH2 directly binds to PCNA, and information regarding whether EZH2 participates in DNA replication remains elusive.

In this study, we demonstrated, for the first time, that EZH2 directly binds to PCNA via the PIP box and promotes methylation at lysine 110. Then, we showed that K110me2 is critical for the stabilization of the PCNA trimer. Finally, we showed that EZH2 promotes the interaction between DNA polymerase δ (POLδ) and PCNA.

Results {#Sec2}
=======

EZH2 regulates HDPC proliferation independent of its role as a gene repressor {#Sec3}
-----------------------------------------------------------------------------

EZH2 is highly expressed in actively proliferating cells and controls cell proliferation by regulating cell cycle checkpoint signalling via histone methyltransferase activity \[[@CR25], [@CR26]\]. First, we investigated how EZH2 influences proliferation through the regulation of checkpoint signalling in hDPCs. shRNA was used to knock down the expression of EZH2 in hDPCs (Fig. [1](#Fig1){ref-type="fig"}a). We observed that hDPC proliferation was strongly impaired upon EZH2 knockdown as indicated by the results of the colony formation assay and growth curves (Fig. [1](#Fig1){ref-type="fig"}b, c). Cells exhibited a reduction in the percentage of cells in S phase. Interestingly, no significant increase in the percentage of cells in either G0/G1 phase or G2/M phase was observed (Fig. [1](#Fig1){ref-type="fig"}d). Our observation was contrary to previous studies in which EZH2 depletion led to an increase in the percentage of cells in G2/M phase \[[@CR31], [@CR32]\]. Fig. 1EZH2-knockdown hDPCs show decreased proliferation, but no transcriptionally significant changes are observed in DNA replication-related genes. **a** Quantitative PCR and western blot show EZH2 knockdown with shRNA in hDPCs (72 h after transduction). **b** Colony formation assay by crystal violet staining demonstrates the viability of EZH2 knockdown hDPCs. **c** Growth curves measured with CCK-8. **d** Flow cytometry analysis shows the cell cycle distribution of EZH2-knockdown hDPCs. **e** Cell cycle RNA-sequencing assay shows the transcripts with significantly altered expression in EZH2-knockdown hDPCs. **f** Quantitative PCR verifies the expression levels of genes identified in the RNA-Seq data. (*ns* not significant, \**P *\< 0.05, \*\**P *\< 0.01, \*\*\**P *\< 0.001)

To experimentally validate these observations, the expression of cell cycle-related genes was measured using a cell cycle RNA-sequencing assay in EZH2-knockdown hDPCs from three different donors. EZH2 has been reported to function as a transcriptional repressor \[[@CR21]\] and represses the expression of *INK4A, INK4B, and ARF* \[[@CR27], [@CR33]\]. In the RNA-sequencing analysis of EZH2-knockdown hDPCs, eight genes were transcriptionally altered (Fig. [1](#Fig1){ref-type="fig"}e); however, there was no transcriptional difference in *INK4A* and *ARF*. Among the eight genes, cyclin-dependent kinase 2 (*CDK2*), cyclin E2 (*CCNE2*), and cyclin-dependent kinase inhibitor 2B (*CDKN2B,* also known as *INK4B*) are involved in controlling cell cycle phase transition \[[@CR26], [@CR34]\]. *CDK2* and *CCNE2*, which also regulate the DNA replication process, were downregulated, and *CDKN2B* was upregulated. Interestingly, when verifying the differentially expressed genes in the RNA-Seq data by qPCR in hDPCs from a fourth donor, we found that only *ANAPC1, CDKN2B,* and *SMAD2* exhibited the same changes in gene expression (Fig. [1](#Fig1){ref-type="fig"}f). These findings are consistent with a previous study showing that Polycomb (PcG) controls the proliferation of mouse embryonic fibroblasts (MEFs) independent of Ink4a/Arf suppression \[[@CR30]\].

Combined with the observation that the defect in proliferation upon EZH2 knockdown did not elicit significant cell cycle arrest at G1 or G2/M phase, our data suggest that instead of canonically controlling transcription at cell cycle phase transitions \[[@CR27]\], EZH2 may regulate the proliferation of hDPCs with an alternative mechanism (Additional file [1](#MOESM1){ref-type="media"}: Figure S1).

EZH2 elevates at S phase in hDPCs and interacts with PCNA {#Sec4}
---------------------------------------------------------

The proliferation of hDPCs was independent of EZH2 transcriptional activity (Fig. [1](#Fig1){ref-type="fig"}). In addition, a previous study showed that PRCs control the proliferation of MEFs instead of functioning in their traditional role as a transcriptional repressor \[[@CR30]\]. Thus, we hypothesized that EZH2 could be directly involved in events during S phase. To investigate this, we first examined the expression dynamics of EZH2 in the cell cycle of hDPCs. hDPCs were synchronized at G0 phase by serum deprivation for 48 h and subsequently released from deprivation by the addition of 10% FBS to allow entry into the cell cycle (Fig. [2](#Fig2){ref-type="fig"}a). Then, cells were harvested at the indicated time points and subjected to flow cytometry to examine the cell cycle distribution (Additional file [2](#MOESM2){ref-type="media"}: Figure S2A); furthermore, the protein level of EZH2 was investigated at the indicated time points. We found that EZH2 protein accumulated at S phase (24 h); however, the levels of trimethylated histone H3 lysine 27 (H3K27me3) were decreased at S phase (Fig. [2](#Fig2){ref-type="fig"}b). Recently, studies reported a lower accumulation of H3K27me3 following DNA replication \[[@CR35], [@CR36]\], which is consistent with our observations. Immunofluorescence was performed at 8 and 24 h, which correspond to G1 phase and S phase, respectively. Consistently, compared to the levels in G1 phase, EZH2 protein levels were increased and had accumulated in the nucleus during S phase (Fig. [2](#Fig2){ref-type="fig"}b, Additional file [2](#MOESM2){ref-type="media"}: Figure S2C left), and the accumulation was further confirmed by Pearson's correlation coefficient analysis of EZH2 and DAPI staining (Additional file [2](#MOESM2){ref-type="media"}: Figure S2C, right). These data indicated a new role for EZH2 in the biological process of S phase independent of catalysing H3K27 trimethylation.Fig. 2EZH2 elevates at S phase in hDPCs and interacts with PCNA. **a** Schematic chart illustrating the serum deprivation approach used for G0/G1 phase synchronization of hDPCs. **b** Western blot shows the expression of EZH2 in hDPCs at the indicated time points after release from serum deprivation. Immunofluorescence shows the subcellular localization of EZH2 in hDPCs in G1 or S phase. **c** Co-immunoprecipitation (Co-IP) of EZH2 and PCNA in hDPCs (synchronized at S phase) and proximity ligation assay (PLA) after co-incubating anti-EZH2 and anti-PCNA antibodies in hDPCs in S phase. IgGs were used as control antibodies for the IP. Antibodies used for IP and western blot are labelled as IP and IB, respectively. Total lysate (10 μg) was used as an input control. Scale bars represent 20 μm

Because cells duplicate their genome during S phase, we hypothesized that EZH2 might participate in the DNA replication of hDPCs in S phase. PCNA, a sliding clamp, is at the heart of DNA synthesis by providing the platform for factors to orchestrate DNA replication \[[@CR4], [@CR37]\]. Additionally, EZH2 has been reported to be present at the replication fork in human cells \[[@CR29], [@CR38]\]. Thus, we investigated whether EZH2 directly interacts with PCNA in hDPCs. We performed co-immunoprecipitation (co-IP) of endogenous EZH2 and PCNA (Fig. [2](#Fig2){ref-type="fig"}c, upper panel). Moreover, by using a proximity ligation assay (PLA) with EZH2- and PCNA-specific antibodies, we visualized the interaction of EZH2 and PCNA at the molecular level (Fig. [2](#Fig2){ref-type="fig"}c, lower panel). Additionally, the interaction of EZH2 and PCNA was verified in 293T cells (data not shown). These results indicate that EZH2 directly interacts with PCNA and strongly indicates the participation of EZH2 in DNA replication.

The presence of a PIP box in EZH2 {#Sec5}
---------------------------------

SET (SU \[VAR\] 3--9, Enhancer of Zeste, Trithorax)-domain proteins usually bind to their catalytic substrates via the SET domain \[[@CR39]--[@CR41]\]. To investigate whether the binding of EZH2 to PCNA also occurs in a SET domain-dependent manner, we transfected 293T cells with *EZH2∆SET* (SET domain-truncated mutation) (Fig. [3](#Fig3){ref-type="fig"}a) and then examined the interaction between EZH2 and PCNA using IP in wild-type *EZH2*- or *EZH2∆SET*-transfected 293T cells. Interestingly, deletion of the SET domain showed no effect on the ability of PCNA to bind EZH2 (Fig. [3](#Fig3){ref-type="fig"}b), suggesting that the interaction between EZH2 and PCNA is governed by other mechanisms rather than the binding of the SET domain. PCNA has been reported to interact with other proteins via the evolutionally conserved PIP box \[[@CR4], [@CR42]\] or the AlkB homologue 2 PCNA-interacting motif (APIM) \[[@CR43]\] present in those proteins. Additionally, histone methyltransferases have also been reported to possess a PIP box motif to interact with PCNA \[[@CR12], [@CR44]\]. Thus, we assessed whether EZH2 contains either a putative PIP box or the APIM. When surveying the amino acid sequence of EZH2, we found a conserved putative PIP box (RVL*I*GT*YY*) (Fig. [3](#Fig3){ref-type="fig"}c) but not the APIM motif. To determine whether EZH2 interacts with PCNA via the putative PIP box, we mutated the conserved amino acid residues isoleucine (*I*) and tyrosine (*Y*) in the PIP box to alanine (*A*) residues (*EZH2∆PIP*) (Fig. [3](#Fig3){ref-type="fig"}d). Then, we performed IP with a FLAG-tagged antibody in 293T cells transfected with wild-type *EZH2* or *EZH2∆PIP*. PCNA was precipitated in cells transfected with wild-type EZH2 but not in cells transfected with EZH2∆PIP (Fig. [3](#Fig3){ref-type="fig"}e). Taken together, these results strongly suggest that EZH2 is a novel PCNA-interacting protein and possesses an evolutionarily conserved PIP box.Fig. 3Presence of a PIP box in EZH2. **a** Schematic representation of FLAG-tagged full-length EZH2 (*EZH2*) and FLAG-tagged SET-domain deletion mutation EZH2 *(EZH2∆SET)*. The lower panel shows the expression of EZH2 in *EZH2*- and *EZH2∆SET*-transfected 293T cells. **b** IP illustrates the binding of PCNA to EZH2 in *EZH2*- and *EZH2∆SET*-transfected 293T cells. **c** The sequence and location of the PIP box in EZH2 homologues of different species. Conserved amino acids are highlighted: *h* represents a hydrophobic amino acid (L/I/M), *a* represents an aromatic (*F*/*Y*), and *x* represents any amino acid. *aa* amino acid. **d** Schematic representation of the full-length EZH2 with mutations of conserved PIP box amino acids (*EZH2∆PIP*). **e** IP shows the interaction of EZH2 and PCNA in *EZH2∆PIP* 293T cells. IgGs were used as control antibodies for IP. Antibodies used for IP and western blot are labelled as IP and IB, respectively

EZH2 methylates PCNA {#Sec6}
--------------------

As a histone lysine methyltransferase, EZH2 promotes the addition of mono-, di- or trimethyl groups onto its histone substrates \[[@CR18]--[@CR20], [@CR45]\]. Moreover, EZH2 has recently been reported to interact with non-histone proteins and to promote the methylation of non-histone proteins \[[@CR22]--[@CR24]\]. Additionally, because our data showed that EZH2 directly interacts with PCNA (Fig. [2](#Fig2){ref-type="fig"}), we hypothesize that PCNA might be a catalytic substrate of EZH2. To evaluate this, we first tested the methylation status of PCNA in hDPCs and 293T cells. Using IP with an anti-PCNA antibody in hDPCs and 293T cells followed by immunoblot with a pan-methyl lysine antibody, we found the presence of methylated lysines on PCNA in both hDPCs and 293T cells (Fig. [4](#Fig4){ref-type="fig"}a). Next, to investigate the role of EZH2 in PCNA methylation, we performed IP with a PCNA antibody in EZH2-knockdown hDPCs or 293T cells and then examined the methylation status of PCNA. In both cases, PCNA methylation was significantly decreased (Fig. [4](#Fig4){ref-type="fig"}b). These data suggested that EZH2 is required for the lysine methylation of PCNA. To further determine whether the methyltransferase activity of EZH2 is necessary for PCNA methylation, we assessed the methylation status of endogenous PCNA in *EZH2∆SET*-transfected 293T cells. Compared to wild-type EZH2, *EZH2∆SET*-transfected 293T cells exhibited markedly decreased methylation of PCNA (Fig. [4](#Fig4){ref-type="fig"}c). Furthermore, to investigate the site at which EZH2 promoted methylation on PCNA, we overexpressed EZH2 in 293T cells, immunoprecipitated endogenous PCNA with an anti-PCNA antibody, and subjected the PCNA gel band to mass spectrometry analysis. A dimethyl modification was identified at the lysine (110) residue of PCNA (Fig. [4](#Fig4){ref-type="fig"}d). Taken together, our data suggested that PCNA is a catalytic substrate of EZH2 and is dimethylated at lysine 110.Fig. 4Methylation of PCNA by EZH2. **a** Pan-lysine methylation of PCNA in hDPCs (S phase) and 293T cells was demonstrated with IP and IB. **b** IP shows the pan-lysine methylation status of PCNA after knocking down EZH2. **c** The pan-lysine methylation of PCNA after overexpressing *EZH2* or *EZH2 ∆SET* in 293T cells. **d** Mass spectrometry analysis of trypsin-digested PCNA by LC--MS/MS. PCNA proteins were immunoprecipitated with anti-PCNA antibody from EZH2-overexpressing 293T cells. The tandem mass-fragmentation spectrum represents the PCNA peptide containing residues 92--110. A mass shift of + 28 was observed. IgGs were used as control antibodies for IP. Antibodies used for IP and western blot are labelled as IP and IB, respectively. Total lysate (10 μg) was used as an input control

Stabilized trimerization of PCNA by EZH2 is essential for the binding of DNA polymerase δ to PCNA {#Sec7}
-------------------------------------------------------------------------------------------------

As a scaffold for DNA polymerases, PCNA plays a crucial role in DNA synthesis \[[@CR37], [@CR46]\]. Thus, we next investigated how EZH2 regulates DNA replication in hDPCs. First, we conducted an EdU pulse assay for 3 h in EZH2-knockdown hDPCs. We found that fewer EZH2-knockdown hDPCs cells were actively synthesizing DNA than wild-type cells, as illustrated by the reduced EdU incorporation (Fig. [5](#Fig5){ref-type="fig"}a). PCNA, a ring-shaped clamp, consists of three homo-monomers arranged in a "head-to-tail" manner in eukaryotes \[[@CR5]--[@CR7], [@CR47]\]. Upon further exploration of the structure of PCNA, we identified that the methylated lysine residue is located on the β-sheet of the PCNA monomer where two monomers meet to establish the "head-to-tail" complex. We therefore hypothesized that EZH2 could regulate the stabilization of the trimer form of PCNA. We then applied a protein crosslink strategy to evaluate the stabilization of the PCNA trimers. EZH2 depletion reduced the formation of the PCNA trimer (Fig. [5](#Fig5){ref-type="fig"}b). We used the same crosslink strategy to investigate whether stabilization of the PCNA trimer was dependent on the protein methylation capacity of EZH2. Stabilization of the PCNA trimer was impaired in cells expressing either the SET domain-truncated mutation or the PIP box mutation (Fig. [5](#Fig5){ref-type="fig"}c). Taken together, our results indicate that EZH2 is essential for the stabilization of the PCNA trimer.Fig. 5Methylation of PCNA at lysine 110 affects the binding of DNA polymerase δ to PCNA. **a** A 3 h EdU pulse was applied in EZH2-knockdown hDPCs at 21 h after release from serum deprivation. Scale bars represent 100 μm. **b** Formaldehyde protein crosslinking assay indicates the presence of the trimer form of PCNA in EZH2-depleted 293T cells. The left panel illustrates the location of lysine 110 on the "head" β-sheet of the interface between the homo-monomers. **c** Crosslink assay shows the level of the trimer form of PCNA in 293T cells overexpressing *EZH2∆SET* and *EZH2∆PIP*. **d** IP demonstrates the decreased interaction between PCNA and POLδ when knocking down EZH2 or overexpressing *EZH2∆PIP* and *EZH2∆SET* in 293T cells. **e** Schematic representation of full-length PCNA with a point mutation at lysine 110 (K110). A Myc tag was added on the C-terminus. The crosslink assay shows the level of trimer PCNA upon lysine 110 mutation (*PCNA∆*). IP demonstrates the binding of POLδ to PCNA when *PCNA∆* is overexpressed in 293T cells. **f** DNA fibre assay demonstrates DNA synthesis in cells expressing the lysine 110 mutant (*PCNA∆*). Origins are indicated by arrows. Scatter plot and bar chart show the DNA length (\*\*\**P* \< 0.001). IgGs were used as a control antibody for IPs. Antibodies used for IP and western blot are labelled as IP and IB, respectively

In normal DNA replication, enhancing the processivity of DNA polymerase δ (POLδ) is the primary function of PCNA \[[@CR46], [@CR48], [@CR49]\]. Thus, we explored whether EZH2 could affect the binding of POLδ to PCNA. First, we immunoprecipitated endogenous PCNA protein using a PCNA antibody to assess the interaction between POLδ (represented by the catalytic subunit, POLD1) and PCNA in hDPCs and 293T cells with EZH2 knockdown. We found decreased binding of POLD1 to PCNA when EZH2 was knocked down (Fig. [5](#Fig5){ref-type="fig"}d). We next investigated whether the binding of POLδ to PCNA depends on the interaction between EZH2 and PCNA by examining the interaction between PCNA and POLδ in *EZH2∆PIP*-transfected 293T cells. We found that the binding of POLD1 to PCNA was dramatically reduced upon mutation of the PIP box (Fig. [5](#Fig5){ref-type="fig"}d). Moreover, we also investigated the effect of the methyltransferase activity of EZH2 on the interaction between PCNA and POLδ. Compared to the cells expressing wild-type *EZH2*, cells transfected with *EZH2 ∆SET* showed decreased levels of POLD1 precipitated with PCNA (Fig. [5](#Fig5){ref-type="fig"}d). Taken together, these results indicate that the methyltransferase activity of EZH2 is necessary for the interaction between PCNA and POLδ.

As our data demonstrated that PCNA can undergo EZH2-mediated dimethylation at lysine 110, we hypothesized that K110me2 may affect the stabilization of the PCNA trimer. We introduced a point mutation at lysine 110 on PCNA (Fig. [5](#Fig5){ref-type="fig"}e), expressed this mutant in 293T cells, and then conducted the protein crosslink assay. As demonstrated, the trimer form of PCNA was dramatically impaired upon mutating PCNA at this residue (Fig. [5](#Fig5){ref-type="fig"}e). Moreover, the binding of POLδ to PCNA was dramatically impaired (Fig. [5](#Fig5){ref-type="fig"}e). Based on the fact that K110A-mutated PCNA exhibited impaired binding to POLδ, we next tested whether this mutant PCNA could affect DNA synthesis. By using a DNA fibre assay, we observed that the DNA length dramatically decreased in cells expressing PCNA with the K110A mutation (Fig. [5](#Fig5){ref-type="fig"}f).

Taken together, our data suggested that the K110me2 catalysed by EZH2 is important for the trimerization of PCNA and the binding of POLδ to PCNA.

Discussion {#Sec8}
==========

Epigenetic modulators such as methyltransferases have been widely studied in the histone lysine methylation field with regard to their modulation of chromatin properties and regulation of gene expression \[[@CR21], [@CR50]--[@CR52]\]. However, owing to growing interest in the post-translational modifications of proteins, the importance of methylation on non-histone proteins has frequently been indicated, and non-histone proteins have been reported to be potential substrates of histone lysine methyltransferases \[[@CR16], [@CR17]\]. In the present study, we demonstrated that PCNA is a novel substrate of EZH2 that can be dimethylated at K110. To date, only three non-histone proteins, RORα, GATA4, and STAT3, have been reported to be substrates of EZH2 \[[@CR22]--[@CR24]\]. In addition, lysine methylation is reversible, and H3K27 has been shown to be demethylated by KDM6B \[[@CR15], [@CR53]\]. Thus, the occurrence of demethylation on PCNA and the verification of de-methyltransferase activity on PCNA need to be elucidated in future. Recently, studies have reported a lower accumulation of H3K27me3 following DNA replication \[[@CR35], [@CR36]\], which is consistent with our observation of decreased H3K27me3 in hDPCs in S phase.

In the present study, we found that knockdown of EZH2 did not induce a significant cell cycle arrest at G1 or G2/M phase, but the proliferation activity of hDPCs was continuously repressed. This was also supported by the observation that the transcript levels of most cell cycle regulatory genes did not change when EZH2 was knocked down in hDPCs. These findings are consistent with previous studies showing that Polycomb (PcG) controls the proliferation of MEFs independent of INK4A/ARF suppression \[[@CR30]\].

PCNA, a sliding clamp, plays a key role in duplicating the genome by providing a scaffold for relevant factors and DNA polymerases. PCNA interacts with DNA replication cofactors during DNA replication via the evolutionarily conserved PIP box or APIM motif \[[@CR4], [@CR43], [@CR54]\]. Previous studies reported that the SET-domain proteins ATXR5 and ATXR6, which have primarily been demonstrated to be H3K27 mono-methyltransferases, interacted with PCNA in Arabidopsis \[[@CR44], [@CR55]\]. In addition, other epigenetic modifiers, such as DNMT1, HDAC1, p300, and SETD8, were reported to interact with PCNA in humans \[[@CR11], [@CR13], [@CR56], [@CR57]\]. So far, SETD8 is the only histone methyltransferase that has been reported to methylate PCNA \[[@CR13]\]. Furthermore, previous studies suggested that in response to DNA damage, EZH2 was recruited to stalled replication forks to function as an H3K27me3 methyltransferase \[[@CR28], [@CR29]\]. However, there was no evidence indicating a direct interaction between EZH2 and PCNA. Here, we provide the first evidence that EZH2 directly interacts with PCNA via the conserved PIP box motif to promote the methylation of PCNA. In the study by Andrea Piunti et al., the association between RING1B and PCNA is reduced in the absence of EZH2, suggesting the possible hierarchical recruitment of PRC1 and PRC2 \[[@CR30], [@CR58]\]. In our study, we confirmed the interaction between EZH2 and PCNA; thus, we hypothesized that the reduced association between RING1B and PCNA was possibly influenced by the diminished interaction between EZH2 and PCNA when EZH2 was depleted. However, this mechanism needs to be verified in future.

PCNA, a ring-shaped complex, consists of three homo-monomers that assemble in a "head-to-tail" manner in eukaryotes \[[@CR4]\]. Maintenance of the PCNA trimer is a prerequisite for promoting the processivity of DNA polymerase δ (POLδ). Here, we uncovered that PCNA K110me2 catalysed by EZH2 is essential for stabilizing the trimer form of PCNA. Moreover, consistent with previous studies \[[@CR30], [@CR59]\], we observed an interaction between SUZ12 and PCNA (data not shown). This suggested that other PRC2 components might be involved in the regulation of PCNA methylation. The trimerization of PCNA is established through the binding of β-sheets of each monomer at the interfaces between the subunits \[[@CR5], [@CR6], [@CR60]\]. Three types of interactions between the monomer interfaces of PCNA have been proposed to stabilize the PCNA trimer: hydrogen bonds, hydrophobic interactions, and ion pairs. Among these, ion pairs between the β-sheets and the interface were considered the main contributor \[[@CR60]\]. Based on the investigation of PCNA among various species, a positive polar amino acid, lysine, was found at position 110, which is located within the β-sheet \[[@CR60]\]. Here, we report that K110me2 is critical for the trimerization of PCNA. Methylation does not perturb the charge of the lysine residue and induces a small change in its size; thus, K110me2 is more likely to enhance the hydrophobic interaction between the monomers to stabilize the PCNA trimer by changing the hydrogen property and hydrophobic force of lysine 110 \[[@CR17], [@CR60], [@CR61]\]. To verify this hypothesis, further structural studies are needed. Moreover, in normal DNA replication, PCNA interacts with POLδ and stimulates its processing activity \[[@CR4], [@CR47], [@CR62], [@CR63]\]. Here, we claimed that EZH2-mediated dimethylation of PCNA K110 is essential for the interaction of PCNA with POLδ, leading to the control of DNA synthesis. Because EZH2 regulates the trimerization of PCNA, it is evident that the binding of POLδ to PCNA decreases in the absence of EZH2.

Conclusion {#Sec08}
==========

In conclusion, our results provide novel evidence that PCNA is a novel lysine methylation substrate of EZH2 and that EZH2 is a new PCNA-interacting protein. EZH2-dependent dimethylation of PCNA K110 is essential for DNA replication because it affects the binding of POLδ to PCNA via stabilization of the PCNA trimer (Fig. [6](#Fig6){ref-type="fig"}). There experiments reveal a novel mechanism through which epigenetic regulators participate and control DNA replication.Fig. 6Predicted model by which EZH2 regulates DNA replication via dimethylation of PCNA. In normal cells, EZH2-mediated dimethylation of PCNA at K110 is required for the DNA replication performed by POLδ. Upon repression of the transcription or the methyltransferase activity of EZH2 or inhibition of the interaction between EZH2 and PCNA, stabilization of the PCNA trimer is perturbed, resulting in a defect in POLδ binding

Methods {#Sec9}
=======

Cell culture {#Sec10}
------------

hDPCs were harvested from normal impacted third molars extracted from adult humans (19--22 years old) in West China Hospital of Stomatology as described previously \[[@CR64]\]. The procedures were approved by the Ethical Committee of the West China School of Stomatology, Sichuan University, and performed in accordance with approved guidelines; all subjects provided informed consent. HEK293T (ATCC) cells were obtained from Ohio (Shanghai). In all experiments, cells were grown in DMEM (GIBCO) supplemented with 10% FBS (GIBCO) and 1% antibiotics (GIBCO). HEK293T cells were cultured in growth medium on plates coated with 0.01% poly-[l]{.smallcaps}-lysine (Sigma-Aldrich). All cells were grown at 37 °C in a humidified atmosphere containing 5% CO~2~.

For G0/G1 synchronization, hDPCs were grown in 0.2% FBS-containing medium for 48 h, after which they were cultured in normal growth medium and harvested at the indicated time points.

Lentivirus production and transduction {#Sec11}
--------------------------------------

Lentivirus expressing *shEZH2* (forward oligo: 5′-CCGG*GAGGGAAAGTGTATGATAA*CTCGAG*TTATCATACACTTTCCCTC*TTTTTG-3′, reverse oligo: 5′-AATTCAAAAA*GAGGGAAAGTGTATGATAA*CTCGAG*TTATCATACACTTTCCCTC***-**3′) was generated by inserting shRNA oligos against *EZH2* into the pLKO.1-TRC cloning vector (gifts from Zhipeng Fan, Capital Medical University) following the Addgene protocol. Oligos were synthesized by Invitrogen. The control vector was also a gift from Zhipeng Fan. Constructs containing wild-type *EZH2*, *EZH2∆SET*, PIP box point mutations of EZH2 (*EZH2∆PIP*), wild-type *PCNA*, or point mutations of PCNA (*PCNA∆*) were acquired from Ohio (Shanghai). Lentiviruses containing shRNA were produced in 293T cells with the following plasmids: 9 µg of pLKO.1 shRNA vector, 6 µg of *∆*8.2 packaging plasmid, and 3 µg of VSV-G envelope plasmid. After 60 h, the supernatant containing viral particles was harvested and filtered at 0.45 μm and added to either hDPCs or 293T cells in the presence of 5 μg/ml polybrene (Sigma-Aldrich) for 48 h. Then, positive cells were selected with 2 μg/ml puromycin (Sigma-Aldrich) for 3 days, and the cells were maintained in growth medium containing 1 μg/ml puromycin.

Western blot analysis {#Sec12}
---------------------

For immunoblots, cells were lysed in protein lysis solution (Pierce Biotechnology) containing protease inhibitor cocktail (Millipore) and phosphatase inhibitor cocktails (Millipore). Protein extraction was performed according to the manufacturer's instructions. For nuclear protein detection, a nuclear extraction procedure was applied following the manufacturer's protocol (Pierce Biotechnology). After the proteins were subjected to standard SDS--polyacrylamide gel (SDS-PAGE) electrophoresis (the percentages were based on the molecular weight of proteins of interest), they were transferred to nitrocellulose membranes (Millipore), which were blocked for 1 h at room temperature in TBST (0.1% Tween-20) containing either 5% skim milk or bovine serum albumin (Sigma-Aldrich). Then, the membranes were incubated overnight at 4 °C with primary antibodies diluted in blocking buffer, washed 5X with TBST, and incubated for 1 h in secondary antibodies diluted in blocking buffer (Table [1](#Tab1){ref-type="table"}). Membranes were washed with Restore Western Blot Stripping Buffer (Thermo) following the manufacturer's protocol. Next, the membranes were washed 5X with TBST, and enhanced chemiluminescence reagent (Millipore) was added to the membranes. Proteins were visualized using ImageLab (Bio-Rad) according to the manufacturer's instructions (Additional file [3](#MOESM3){ref-type="media"}: Figure S3).Table 1Antibodies used in this studyAntibodyBrandCat no.UseConditionEZH2BD612666WB, IF1:2000, 1:200EZH2 (AC22)Merck Millipore17-662IP2/500 μgEZH2R&DAF4767PLA1:50Histone H3Abcamab24834WB1:1000α-TubulinAbcamab52866WB, IF1:5000, 1:500H3K27me3(C36B11)Cell signalling9733WB1:2000PCNA (PC10)Cell signalling2586WB, IF, PLA, IP1:5000, 1:200Pan-methyl lysineAbcamab7315WB1:2000DNA Polymerase delta (607)Abcamab10362WB1:1000CYCLIN A2Abcamab38WB1:500CYCLIN D1Abcamab40754WB1:5000FLAG-tagSigmaF7425WB, IP1:2000, 1:100Myc-TagCell signalling2278WB, IP1:4000, 1:200Ubiquityl-PCNA (Lys164) (D5C7P)Cell signalling13439WB1:1000Histone H2AXAbcamAb11175WB1:2500γ-H2A.XCell signalling9718WB1:2000Goat anti-rabbit IgG (HRP)Abcamab6721WB1:10,000Goat anti-mouse IgG (HRP)Abcamab6789WB1:10,000Rabbit anti-goat IgG-FITCBosterBA1110IF1:60Rabbit anti-goat IgG-Cy3BosterBA1034IF1:60Goat anti-mouse IgG-Cy3BosterBA1031IF1:60Goat anti-mouse IgG-FITCBosterBA1101IF1:60Goat anti-rabbit IgG-Cy3BosterBA1032IF1:60Donkey anti-mouse IgG (H + L)(Alexa Fluor 555)BeyotimeA0460IF1:500Anti-IdUNovusNBP2-44056DNA fibre1:300

Cell proliferation assays {#Sec13}
-------------------------

### Growth curves {#Sec14}

hDPCs were seeded in 96-well plates at a density of 3 × 10^3^ cells per well in triplicate for each time point, and the medium was changed every 2 days. To determine the cell viability, a 7-day time course was implemented, and a 10-μl CCK-8 solution (Dojindo) was added every 2 days and incubated for 1.5 h according to the manufacturer's protocol. The absorbance at 450 nm was measured by a microplate reader (BioTek) and normalized to the background readings.

Colony formation assay {#Sec15}
----------------------

hDPCs were seeded in a six-well plate at a density of 500 cells/well and cultured in growth medium for 3 wks. Cells were washed with PBS, fixed in a 4% paraformaldehyde for 5 min, and then stained with crystal violet (Beyotime) for 5 min.

Flow cytometry analysis {#Sec16}
-----------------------

To analyse the cell cycle distribution, trypsinized cells were washed with PBS and fixed in ice-cold 70% ethanol overnight. Cells were then washed 2X with PBS and incubated with RNase for 30 min at 37 °C followed by incubation with propidium iodide (PI) (KeyGEN Biotech) for 30 min at 4 °C. The PI-stained cells were examined on a Guava EasyCyte HT flow cytometer (Millipore) and analysed with InCyte2.7 software (Millipore).

RNA-sequencing analysis {#Sec17}
-----------------------

hDPCs from three different donors were collected, treated with TRIzol (Invitrogen) and subjected to cell cycle RNA sequencing (RiboBio) to detect the transcripts of cell cycle-related genes. Array and data were performed and analysed by RiboBio Inc. (Guangzhou). Genes with an expression fold change ≥ 1.5 and *P* ≤ 0.05 were considered differentially expressed. RNA-Seq data are available upon demand from the corresponding author.

qPCR {#Sec18}
----

Total RNA was extracted using TRIzol (Invitrogen) according to the manufacturer's protocol. Reverse transcription was performed with a PrimeScript^®^ RT reagent kit with gDNA Eraser (TaKaRa). Quantitative real-time PCR was carried out using a standard SYBR Green PCR kit (TaKaRa) on a CFX96 (Bio-Rad). Glyceraldehyde-3-phosphate dehydrogenase (*GAPDH*) was used to normalize the expression level of each gene. Primer pairs for each gene were as follows:*GAPDH*: 5′-CGGAGTCAACGGATTTGGTCGTAT-3′ and 5′-AGCCTTCTCCATGGTGGTGAAGAC-3′;EZH2: 5′-GCCAGACTGGGAAGAAATCTG-3′ and 5′-TGTGCTGGAAAATCCAAGTCA-3′;*CDK2*: 5′-GGCACGTACGGAGTTGTGTA-3′ and 5′-CTCAGTCTCAGTGTCCAGGC-3′;*ANAPC1*: 5′-AGGCCTGCGAAGGAAACTTA-3′ and 5′-ACGTTGACACGGACAGGATG-3′;*CDKN2B*: 5′-GAATGCGCGAGGAGAACAAG-3′ and 5′-CATCATCATGACCTGGATCGC-3′;*SMAD2*: 5′-GCTTCCCTCGTGCTGATTGG-3′ and 5′-GTATGGAAGACGGAGGGAGC-3′;*CCNE2*: 5′-GGCCTATATATTGGGTTGGCG-3′ and 5′-ACGGCTACTTCGTCTTGACA-3′;*MCM2*: 5′-ATCTACGCCAAGGAGAGGGT-3′ and 5′-GTAATGGGGATGCTGCCTGT-3′;*BUB1B*: 5′-GGATGGGTCCTTCTGGAAAC-3′ and 5′-AAGCTCCCCAAGAACAGACA-3′;*CDC27*: 5′-GACAGCTCCACAACCAAGGA-3′ and 5′-TCAAACCTTCTGCTGCTGCT-3′.

Immunofluorescence staining {#Sec19}
---------------------------

hDPCs were seeded on coverslips overnight before serum deprivation. Cells were fixed with 4% paraformaldehyde in PBS at room temperature for 15 min and then permeabilized with 0.5% Triton X-100 in PBS for 20 min at room temperature. Cells were blocked for 30 min with blocking buffer (Zhongshanjinqiao) and incubated overnight at 4 °C with primary antibodies in blocking solution. Coverslips were washed 5X with PBST (0.5% Tween-20) and incubated for 1 h at room temperature with fluorescent secondary antibodies (Table [1](#Tab1){ref-type="table"}). Next, the coverslips were washed 5X with PBST (0.5% Tween-20) and then stained with 4′6-diamidino-2-phenylindole (DAPI) to identify nuclear DNA. Images were captured on a Nikon Eclipse 300 fluorescence microscope (CompixInc). ImageJ was used to calculate Pearson's correlation coefficient and Mender's coefficient of colocalization.

5-Ethynyl-2′-deoxyuridine (EdU) staining {#Sec20}
----------------------------------------

EdU staining was conducted using an EdU imaging kit (RiboBio) according to the manufacturer's protocol. Briefly, hDPCs were seeded on coverslips overnight followed by serum starvation. Then, cells were released from deprivation in complete growth medium for 24 h, during which an EdU pulse was applied for 3 h at a concentration of 50 μM. After labelling, cells were stained with EdU. For double staining with other antigens, additional immunohistochemical staining was performed following EdU staining before the nuclei were stained with DAPI. Images were captured with a Nikon Eclipse 300 fluorescence microscope (CompixInc).

Proximity ligation assay {#Sec21}
------------------------

Cells were prepared as described in the immunofluorescence section and incubated with anti-EZH2 (Goat) and anti-PCNA (mouse) primary antibodies following the manufacturer's instructions (Sigma-Aldrich). Briefly, cells were incubated for 60 min at 37 °C with anti-mouse PLUS (Sigma-Aldrich, DUO92001) and anti-Goat MINUS (Sigma-Aldrich, DUO92006), washed twice with Buffer A (Sigma-Aldrich, DUO82047), and then incubated with the ligation solution (Sigma-Aldrich, DUO92014) for 30 min at 37 °C. After ligation, cells were washed twice with Buffer A and then incubated for 100 min at 37 °C with amplification reagents (Sigma-Aldrich, DUO92014). Finally, the cells were washed three times with Buffer B (Sigma-Aldrich, DUO82048), stained, and mounted with mounting medium (Sigma-Aldrich, DUO82040) to visualize the nuclei. Images were captured with a Nikon Eclipse 300 fluorescence microscope (CompixInc).

Immunoprecipitation {#Sec22}
-------------------

Cells were harvested at the indicated times, lysed in lysis buffer supplemented with a protease inhibitor cocktail, incubated on ice for 20 min, and cleared by centrifugation at 14,000 rpm at 4 °C for 20 min. Total protein lysate (500 μg) was incubated with agarose-conjugated protein A/G beads for 2 h at 4 °C; the lysate was washed 5X with PBS at 4 °C and centrifuged at 14,000 rpm at 4 °C for 20 min. Then, the lysate was subjected to immunoprecipitation with agarose (Beyotime)-immobilized antibodies or isotype control antibodies overnight at 4 °C. The mix was washed 3X with lysis buffer at 4 °C. The precipitated proteins were subjected to SDS-PAGE and detected by western blot.

Formaldehyde crosslinking {#Sec23}
-------------------------

Formaldehyde crosslinking assays were performed as previously described \[[@CR65]\]. Trypsinized cells were resuspended and incubated in a 1.0--1.5% formaldehyde solution at room temperature for 30 min. Then, the reaction was quenched by the addition of a 1.5 M glycine solution to a final concentration of 0.15 M and incubated at room temperature for 5 min. Cells were pelleted by centrifugation at 4000 rpm at room temperature for 5 min and resuspended and washed twice in PBS. Products were analysed by western blot using PCNA (PC10) or Myc-tagged antibodies.

DNA fibre assay {#Sec24}
---------------

A DNA fibre assay was performed according to a previous study \[[@CR66]\]. Briefly, 293T cells were labelled with 25 μM IdU (Sigma-Aldrich, I17125) for 2 h. A 2-μl cell suspension was spotted at the end of the microscope slide and incubated with 7 μl of lysis buffer (0.5% SDS, 200 mM Tris--HCl (pH 7.4), and 50 mM EDTA) for 2 min. Slides were tilted 15° to allow the DNA fibres to stretch along the slide and then allowed to air-dry. After 10 min of fixation in methanol:acetic acid (3:1), the DNA was denatured with 2.5 M HCl for 60 min and blocked in 5% BSA in PBS (Table [1](#Tab1){ref-type="table"}).

Slides were incubated with primary antibodies (anti-IdU), washed three times in PBS, incubated with secondary antibodies, and mounted.

Statistical analysis {#Sec25}
--------------------

The statistical analysis of the RNA sequencing was calculated with ANOVA, whereas the statistical analysis of other experiments was carried out with Student's *t test* (two-tailed) using Prism 5 (GraphPad Software). Error bars represent the standard deviation (SD). *P* values \< 0.05 were considered statistically significant. \**P* \< 0.05, \*\**P* \< 0.01, and \*\*\**P* \< 0.001. All experiments were repeated three times biologically unless specifically indicated.

Additional files
================

 {#Sec26}

**Additional file 1: Figure S1 (related to Fig.** **1).** A: Immunoblot shows the H3K27me3 level in EZH2-knockdown hDPCs. B: The morphology of hDPCs with EZH2 knockdown. C: Quantification of colony-forming ability of hDPCs with EZH2 knockdown. D: Charts represent genes in the cell cycle RNA-sequencing assay that are involved in DNA replication based on the AmiGO 2 database. (*ns* not significant, \**P *\< 0.05, \*\**P *\< 0.01, \*\*\**P *\< 0.001). Scale bar represents 100 μm **Additional file 2: Figure S2 (related to Fig.** **2).** A: Flow cytometry shows the cell cycle distribution of hDPCs from one donor at the indicated time points after release from serum deprivation. B: Immunoblot demonstrates the expression of CYCLIN D1 and CYCLIN A2, indicating G1 phase and S phase, respectively. α-TUBULIN was used a loading control of whole lysate. C: Statistical analysis of the EZH2-positive ratio (Left, *n* = 3) and Pearson's correlation coefficient of EZH2 with DAPI (right, each dot represents one cell). D: Statistical analysis of the PLA-positive ratio (left, *n* = 5). The PLA signals are associated with DAPI on a single-cell basis (\*\*\**P* \< 0.001) **Additional file 3: Figure S3.** Uncut immunoblots from the immunoprecipitation experiments
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